Evaluation of a clinically applicable mutation screening technique for genetic diagnosis of familial hypercholesterolemia and familial defective apolipoprotein B

Clinical Genetics

Volumn 53, Issue 6, 1998, Pages 433-439

  Nissen, Henrik ^a   Hansen, Annebirthe B ^a   Guldberg, Per ^b   Hansen, Torben S ^a   Petersen, Niels E ^a   Hørder, Mogens ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b JOHN F KENNEDY INSTITUTE   (Denmark)

Author keywords

Diagnostics; Familial defective apolipoprotein B 100; Familial hypercholesterolemia; Genetics

Indexed keywords

APOLIPOPROTEIN B;

ARTICLE; CODON; DENATURING GRADIENT GEL ELECTROPHORESIS; DENMARK; EXON; FAMILIAL DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; FAMILY; GENE MUTATION; GENETIC COUNSELING; HUMAN; POINT MUTATION; PRIORITY JOURNAL; SCREENING TEST; SEGREGATION ANALYSIS; SOUTHERN BLOTTING;

EID: 0031869304     PISSN: 00099163     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-0004.1998.tb02591.x     Document Type: Article

References (29)

1. Goldstein JL, Hobbs HH, Brown MS. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Diseases, 7th edn. New York: McGraw-Hill, 1995: 1981-2030.
2. Myant NB. Familial defective apolipoprotein B-100: a review, including some comparisons with familial hypercholesterolemia. Atherosclerosis 1993: 104: 1-18.
3. Soria LF, Ludwig EH, Clarke HR, Vega GL, Grundy SM, McCarthy BJ. Association between a specific apolipoprotein B polymorphism and familial defective apolipoprotein B-100. Proc Natl Acad Sci USA 1989: 86: 587-591.
4. Pullinger CR, Hennessy LK, Chatterton JE, Liu W, Love JA, Mendel CM, Frost PH, Malloy MJ, Schumaker VN, Kane JP. Familial ligand-defective apolipoprotein B. Identification of a new mutation that decreases LDL receptor binding affinity. J Clin Invest 1995: 95: 1225-1234.
5. Gaffney D, Reid JM, Cameron IM, Vass K, Caslake MJ, Shepard J, Packard CJ. Independent mutations at the codon 3500 of the apolipoprotein B gene are associated with hyperlipidemia. Arterioscler Thromb Vasc Biol 1995: 15: 1025-1029.
6. Nissen H, Guldberg P, Hansen AB, Petersen NE, Hørder M. Clinically applicable mutation screening in familial hypercholesterolemia. Human Mutation 1996: 8: 168-177.
7. Nissen H, Guldberg P, Hansen AB, Hansen TS, Petersen NE, Hørder M. Detection and characterization of a novel splice mutation in the LDL receptor intron 12 resulting in two different mutant mRNA variants. Atherosclerosis 1997: 128: 75-83.
8. Nissen H, Hansen AB, Guldberg P, Petersen NE, Hørder M. Phenotypic presentation of the FH-Cincinnati type 5 low density lipoprotein receptor mutation: Genetic analysis adds independent diagnostic information in familial hypercholesterolemia. Scand J Clin Lab Invest 1996: 56: 75-85.
9. Nissen H, Hansen AB, Guldberg P, Petersen NE, Larsen ML, Haghfelt T, Kristiansen K, Hørder M. Detection of a single base deletion in codon 424 of the low density lipoprotein receptor gene in a Danish family with familial hypercholesterolemia. Atherosclerosis 1994: 111: 209-215.
10. Christensen NC, Hørder M. Familial hyperlipidemia. A study of 152 members of 26 families. Danish Med Bull 1970: 18: 100-104.
11. Nissen H, Hansen AB, Guldberg P, Petersen NE, Larsen ML, Haghfelt T, Kristiansen K, Hørder M. Genetic diagnosis with the denaturing gradient gel electrophoresis technique improves diagnostic precision in familial hypercholesterolemia. Circulation 1995: 91: 1641-1646.
12. Sheffield VC, Cox DR, Lerman LS, Myers RM. Attachment of a 40 base G + C rich sequence (GC-clamp) to genomic DNA fragments by the polymerase chain reaction results in improved detection of single base changes. Proc Natl Acad Sci USA 1989: 86: 232-236.
13. Rüdiger N, Hansen PS, Jørgensen M, Færgeman O, Bolund L, Gregersen N. Repetetive sequences involved in the recombination leading to deletion of exon 5 of the low-density-lipoprotein receptor in a patient with familial hypercholesterolemia. Eur J Biochem 1991: 198: 107-111.
14. Yamamoto T, Davis CG, Brown MS, Schneider WJ, Casey ML, Goldstein JL, Russell DW. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell 1984: 39: 27-38.
15. Soutar AK. A polymorphism in exon 2 of the human LDL-receptor gene (LDLR). Nucleic Acids Res 1992: 19: 4314.
16. Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1992: 1: 445-466.
17. Jensen HK, Jensen LG, Hansen PS, Faergeman O, Gregersen N. High sensitivity of the single-strand conformation polymorphism method for detecting sequence variations in the low-density lipoprotein receptor gene validated by DNA sequencing. Clin Chem 1996: 42: 1140-1146.
18. Koivisto PV, Koivisto UM, Miettinen TA, Kontula K. Diagnosis of heterozygous familial hypercholesterolemia. DNA analysis complements clinical examination and analysis of serum lipid levels. Arterioscler Thromb 1992: 12: 584-592.
19. Haba T, Sakai Y, Koizumi J, Miyamoto S, Mabuchi H, Takeda R. A case of heterozygous familial hypercholesterolemia associated with hyperthyroidism: effects of triiodothyronine on low-density lipoprotein receptor and cholesterol synthesis. Metabolism 1983: 32: 1129-1132.
20. Lombardi P, Sijbrands EJG, Kamerling S, Leuven JAG, Havekes LM. The T705I mutation of the low density liporotein receptor gene (FH Paris-9) does not cause familial hypercholesterolemia. Hum Genet 1997: 99: 106-107.
21. Ekström U, Abrahamson M, Sveger T, Lombardi P, Nilsson-Ehle P. An efficient screening procedure detecting 6 novel mutations in the LDL receptor gene in Swedish children with hypercholesterolemia. Hum Genet 1995: 96: 147-150.
22. Lombardi P, Sijbrands EJG, van de Giesen K, Smelt AHM, Kastelein JJ, Frants RR, Havekes LM. Mutations in the low density lipoprotein receptor gene of familial hypercholesterolemic patients detected by denaturing gradient gel electrophoresis and direct sequencing. J Lipid Res 1995: 36: 860-867.
23. Guldberg P, Henriksen KF, Güttler F. Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis. Genomics 1993: 17: 141-146.
24. Tartary M, Vidaud D, Piao Y, Costa JM, Bahnak BR, Fressinaud E, Congard B, Laurian Y, Meyer D, Lavergne JM, Vidaud M. Detection of a molecular defect in 40 of 44 patients with haemophilia B by PCR and denaturing gradient gel electrophoresis. Br J Haematol 1993: 84: 662-669.
25. Webb JC, Patel DD, Shoulders CC, Knight BL, Soutar AK. Genetic variation at a splicing branch point in intron 9 of the low density lipoprotein (LDL)-receptor gene: a rare mutation that disrupts mRNA splicing in a patient with familial hypercholesterolemia and a common polymorphism. Hum Mol Genet 1996: 5: 1325-1331.
26. Yokoyama C, Wang X, Briggs MR, Admon A, Wu J, Hua X, Goldstein JL, Brown MS. SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls transcription of the low density lipoprotein receptor gene. Cell 1993: 75: 187-197.
27. Hua X, Yokoyama C, Wu J, Briggs MR, Brown MS, Goldstein JL, Wang X. SREBP-2, a second basic-helix-loop-helix-leucine zipper protein that stimulates transcription by binding to a sterol regulatory element. Proc Natl Acad Sci USA 1993: 90: 11603-11607.
28. Hua X, Goldstein JL, Brown MS, Hobbs HH. Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. Genomics 1995: 25: 667-673.
29. Rüdiger N, Heinsvig EM, Hansen FA, Færgeman O, Bolund L, Gregersen N. DNA deletions in the low density lipoprotein (LDL) receptor gene in Danish families with familial hypercholesterolemia. Clin Genet 1991: 39: 451-462.